ID   HeLa Kyoto EGFP-H2B
AC   CVCL_1D63
SY   HeLa Kyoto H2B-EGFP; HeLa Kyoto H2B EGFP; HeLa-H2B-GFP
DR   CLS; 300673
DR   Wikidata; Q54882543
RX   PubMed=19203582;
RX   PubMed=20360735;
CC   Population: African American.
CC   HLA typing: A*:68:02:01; B*:15:03:01; C*:12:03:01; DPB1*01:01:01; DQA1*01:01:02; DQB1*05:01:01; DRB1*01:02:01 (CLS=300673).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1922 ! HeLa Kyoto
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
RX   PubMed=19203582; DOI=10.1016/j.cell.2008.12.020;
RA   Steigemann P., Wurzenberger C., Schmitz M.H.A., Held M., Guizetti J.,
RA   Maar S., Gerlich D.W.;
RT   "Aurora B-mediated abscission checkpoint protects against
RT   tetraploidization.";
RL   Cell 136:473-484(2009).
//
RX   PubMed=20360735; DOI=10.1038/nature08869; PMCID=PMC3108885;
RA   Neumann B., Walter T., Heriche J.-K., Bulkescher J., Erfle H.,
RA   Conrad C., Rogers P., Poser I., Held M., Liebel U., Cetin C.,
RA   Sieckmann F., Pau G., Kabbe R., Wunsche A., Satagopam V.,
RA   Schmitz M.H.A., Chapuis C., Gerlich D.W., Schneider R., Eils R.,
RA   Huber W., Peters J.-M., Hyman A.A., Durbin R., Pepperkok R.,
RA   Ellenberg J.;
RT   "Phenotypic profiling of the human genome by time-lapse microscopy
RT   reveals cell division genes.";
RL   Nature 464:721-727(2010).
//